Hanson Wade Group has taken the decision to cancel this meeting. Please accept our apologies for any inconvenience or disappointment this may cause. Please register your interest here if you would like updates on the meeting or topic.
Prioritize Safety, Maximize Efficacy, Improve Patient Access
The 6th Gene Therapy Immunogenicity Summit is an essential event for biotech and pharma companies looking to drive innovation and success in the rapidly evolving gene therapy landscape. Immunogenicity remains one of the most significant hurdles to the safe and effective development of gene therapies, particularly with challenges in:
Translational Medicine
Pharmacology
Non-Clinical Development
Toxicology
Clinical Development
Bioanalysis
By attending, you’ll join your peers and gain exclusive access to the latest scientific advancements, real-world case studies, and actionable strategies from industry pioneers.
This summit provides a unique platform to connect with experts, foster partnerships, and gain the critical insights needed to de-risk development pipelines, optimize therapeutic outcomes, and stay ahead in this highly competitive space.
World Class Speaker Faculty Includes:
